With a huge push to reduce opioid prescribing, little is known about the real-world benefits or risks to patients. A recent study published in the Journal of General
Patients with non-small cell lung cancer (NSCLC) now have more improved treatment options compared to standard of care with the addition of several new agents called immune-checkpoint inhibitors
Since its approval in April 2019, dacomitinib has been available for the first-line treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with
Every year since 2013, the UK’s Office for National Statistics has reported an increase in drug-related deaths in England. Last year, we reported that drugs had overtaken traffic
A team led by Michael Trauner at MedUni Vienna’s Division of Gastroenterology and Hepatology demonstrated the beneficial effect of synthetically produced bile acid with the active agent nor-ursodeoxycholic
This week (25 July) the Genomics of Drug Sensitivity in Cancer project has released the results of four years of intense data gathering and exploration which will power
It’s an unforeseen side effect of the nation’s opioid epidemic: Adolescent heroin users. A USC study in the July 8 issue of JAMA Pediatrics shows that teens who
(HealthDay)—As America grapples with an opioid epidemic, it has become even more important to dispose of your leftover prescription medications properly, one pharmacist says. “Many people don’t realize
A group of researchers funded by Neuroendocrine Tumor Research Foundation (NETRF) has discovered molecular information that may predict recurrence of non-functional pancreatic neuroendocrine tumors (pNETs), which do not
U.S. hospitals wait over a year on average to begin prescribing newly developed antibiotics, a delay that might threaten the supply or discourage future development of needed drugs.
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok
